膜融合车辆用于重新敏感化癌症中载体介导的多种药物耐药性
Sahel Vahdati1,2, Alf Lamprecht1
1Departments of Pharmaceutics, Institute of Pharmacy, University of Bonn, 53121 Bonn, Germany.
Pharmaceutics
|April 27, 2024
概括
膜融合车辆 (MFV) 有效地输送环素A (CsA),以通过ABC载体调解反转多药性耐药性 (MDR). 这种有针对性的输送使用较低的度,并揭示载体结合位点的差异.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 多种药物耐药性 (MDR) 在医学中构成了重大挑战,通常源于ATP结合盒 (ABC) 载体的过度表达.
- 目前的这些流量载体的抑制剂经常表现出高毒性或水溶性差,限制了它们的治疗效果.
- 开发有效的策略来克服MDR需要新的药物递送系统,可以增强抑制剂的功效和减少副作用.
研究的目的:
- 通过使用膜融合车辆 (MFV) 直接将ABCB1,ABCC1和ABCG2载体的抑制剂环素A (CsA) 输送到细胞膜的疗效.
- 为了比较通过MFVs交付的CSA与溶液中的CSA的MDR逆转能力.
- 探索MFV在阐明传送器结合位点特异性的潜力.
主要方法:
- 使用了三个转染的MDCK II细胞系,与父细胞一起过度表达ABCB1,ABCC1和ABCG2.
- 给药的CsA装入MFV,直接进入细胞膜.
- 将溶液中CSA的抑制度 (IC50) 与逆转MDR的MFV进行了比较.
- 研究了MFVs和CsA度对Hoechst 33342流动的影响.
主要成果:
- 与溶液中的CsA相比,装载CsA的MFV在较低度下显著逆转了所有三种测试的ABC载体介导的MDR.
- 观察到IC50值的大幅降低:ABCB1的15倍,ABCC1的7倍,ABCG2.2的11倍.
- 对于ABCB1和ABCG2载体,已证明结合位点的特异性.
- 确定MFVs,除了药物输送之外,可以调节输送器活动并帮助区分结合部位.
结论:
- 多功能车辆为CSA提供了有效的交付系统,克服了传统管理的局限性,并大大提高了其MDR逆转潜力.
- 在MFV输送系统允许使用较低,较少毒性度的CsA.
- 这种方法提供了对ABC传送器,特别是ABCB1和ABCG2.2的独特绑定特征的见解.
关键词:
在ABC运输器上,运输器是ABC.在ABCB1 (P-gp) 中.在ABCC1 (MRP1) 中.在ABCG2 (BCRP) 中.循环氨酸A 是一种细胞质递送是细胞质递送.融合性脂质体是一种融合性脂质体.膜融合式汽车的使用情况多药性耐药性 (MDR) 是一种多药性耐药性.更多相关视频
10:46A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
3.6K
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.2K
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Carrier-Mediated Transport
415
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
415
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
The Significance of Membrane Transport
25.5K
The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
25.5K
Cellular Membranes and Drug Transport
502
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
502
Membrane Transporters
10.8K
Transporters are essential membrane transport proteins with functions related to cell nutrition, homeostasis, communication, etc. Approximately 7% of all genes in the human genome code for transporters or transporter-related proteins.
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
10.8K
